-
![Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same](/abs-image/US/2006/09/28/US20060217412A1/abs.jpg.150x150.jpg)
1.发明申请Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same 审中-公开咪唑并恶唑并[4,5-b]吡啶和咪唑并稠合的噻唑并[4,5-b]吡啶三环化合物和包含它们的药物组合物公开(公告)号：US20060217412A1
公开(公告)日：2006-09-28
申请号：US11444856
申请日：2006-06-01
申请人： William Pitts , Makonen Belema , Patrice Gill , James Kempson , Yuping Qiu , Claude Quesnelle , Steven Spergel , Fred Zusi
发明人： William Pitts , Makonen Belema , Patrice Gill , James Kempson , Yuping Qiu , Claude Quesnelle , Steven Spergel , Fred Zusi
IPC分类号： A61K31/4745 , C07D498/14 , C07D491/14
CPC分类号： C07D513/14
摘要： The present invention provides for pyrazolopurine-based tricyclic compounds having the formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.
摘要翻译： 本发明提供具有式（I）的吡唑并嘌呤类三环化合物，其中R 1，R 2，R 3，R 3， SUP> 4，R 5和R 6如本文所述。 本发明还提供包含这些化合物的药物组合物，以及这些化合物用于治疗炎症和免疫疾病的用途。
-
![Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same](/abs-image/US/2005/05/12/US20050101626A1/abs.jpg.150x150.jpg)
2.发明申请Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same 有权咪唑并稠唑并[4,5-β]吡啶和咪唑并稠合噻唑并[4,5-β]吡啶三环化合物和包含它们的药物组合物公开(公告)号：US20050101626A1
公开(公告)日：2005-05-12
申请号：US10848412
申请日：2004-05-18
申请人： William Pitts , Makonen Belema , Patrice Gill , James Kempson , Yuping Qiu , Claude Quesnelle , Steven Spergel , Fred Zusi
发明人： William Pitts , Makonen Belema , Patrice Gill , James Kempson , Yuping Qiu , Claude Quesnelle , Steven Spergel , Fred Zusi
IPC分类号： A61K31/4353 , A61K31/4745 , C07D20060101 , C07D213/72 , C07D471/02 , C07D491/14 , C07D498/12 , C07D498/14 , C07D513/12 , C07D513/14
CPC分类号： C07D513/14
摘要： The present invention provides for pyrazolopurine-based tricyclic compounds having the formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.
摘要翻译： 本发明提供具有式（I）的吡唑并嘌呤类三环化合物，其中R 1，R 2，R 3，R 3， SUP> 4，R 5和R 6如本文所述。 本发明还提供包含这些化合物的药物组合物，以及这些化合物用于治疗炎症和免疫疾病的用途。
-
3.发明申请Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same 有权基于三唑基嘌呤的三环化合物和包含它们的药物组合物公开(公告)号：US20050038054A1
公开(公告)日：2005-02-17
申请号：US10901677
申请日：2004-07-29
申请人： Donald Combs , Charles Langevine , Yuping Qiu , Fred Zusi
发明人： Donald Combs , Charles Langevine , Yuping Qiu , Fred Zusi
IPC分类号： A61K20060101 , A61K31/519 , C07D487/14
CPC分类号： C07D487/14
摘要： The present invention provides for triazolopurine-based tricyclic compounds having the formula (I), wherein R1, R2, R3, R4, and R5 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.
摘要翻译： 本发明提供具有式（I）的三唑并嘌呤类三环化合物，其中R 1，R 2，R 3，R 4和R 5如本文所述。 本发明还提供包含这些化合物的药物组合物，以及这些化合物用于治疗炎症和免疫疾病的用途。
-
-
搜索结果
3 条记录 (耗时 0.032 秒)
